SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-018632
Filing Date
2020-03-12
Accepted
2020-03-12 19:02:58
Documents
1
Period of Report
2020-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3793
  Complete submission text file 0001209191-20-018632.txt   5259
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE - SUITE 3502 NEW YORK NY 10036
Business Address
Ratcliffe Liam (Reporting) CIK: 0001547100 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39231 | Film No.: 20710266

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)